of complete
of complete
Laboratory value | Result |
Blood Gases, Serum | |
pH | 7.23 |
PCO2 | 55 mmHg |
PO2 | 30 mmHg |
2024
2023
2022
2021
neonatal respiratory distress syndrome as cause p. 679
neonatal respiratory distress syndrome p. 679
neonatal respiratory distress syndrome p. 679
neonatal respiratory distress syndrome as cause p. 679
neonatal respiratory distress syndrome p. 679
neonatal respiratory distress syndrome and p. 679
restrictive lung disease p. 694
neonatal respiratory distress syndrome and p. 679
neonatal respiratory distress syndrome and p. 679
Infant respiratory distress syndrome (IRDS), also called neonatal respiratory distress syndrome, is a syndrome common in premature infants that is caused by developmental insufficiency of surfactant production and structural immaturity in the lungs. The result is inability to exchange oxygen and carbon dioxide effectively across the alveolar-capillary membrane.
Symptoms of RDS may include rapid breathing, grunting, flaring of the nostrils, and cyanosis (bluish skin and lips). The severity of the symptoms can vary depending on the severity of the RDS. Treatment for RDS may include supplemental oxygen, respiratory support, and medications to improve lung function.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.